Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients

Neuroscience Letters

Volumn 530, Issue 1, 2012, Pages 97-102

  Gilabert Juan, Javier ^a,b,c   Varea, Emilio ^a   Guirado, Ramón ^a,d   Blasco Ibáñez, José Miguel ^a   Crespo, Carlos ^a   Nácher, Juan ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto Universitario IVI INCLIVA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Glutamate decarboxylase; Major depression; PSA NCAM; Schizophrenia; Structural plasticity; Synaptophysin

Indexed keywords

GLUTAMATE DECARBOXYLASE 67; NERVE CELL ADHESION MOLECULE; POLYSIALYLATED NEURAL CELL ADHESION MOLECULE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

AMYGDALOID NUCLEUS; ARTICLE; BIPOLAR DEPRESSION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MENTAL DISEASE; NERVE CELL PLASTICITY; NEUROPIL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ADULT; AGED; AMYGDALA; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HUMANS; MENTAL DISORDERS; MIDDLE AGED; NEURAL CELL ADHESION MOLECULE L1; NEURAL INHIBITION; NEURONAL PLASTICITY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SIALIC ACIDS; SYNAPSES; SYNAPTOPHYSIN; VESICULAR GLUTAMATE TRANSPORT PROTEIN 1;

EID: 84868304259     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.09.032     Document Type: Article

References (41)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry 1995, 52:258-266.
2. Barbeau D., Liang J.J., Robitalille Y., Quirion R., Srivastava L.K. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:2785-2789.
3. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives of General Psychiatry 1991, 48:996-1001.
4. Bird E.D., Spokes E.G., Barnes J., MacKay A.V., Iversen L.L., Shepherd M. Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 1977, 2:1157-1158.
5. Brennaman L.H., Maness P.F. NCAM in neuropsychiatric and neurodegenerative disorders. Advances in Experimental Medicine and Biology 2010, 663:299-317.
6. Castillo-Gómez E., Gómez-Climent M.A., Varea E., Guirado R., Blasco-Ibáñez J.M., Crespo C., Martínez-Guijarro F.J., Nácher J. Dopamine acting through D2 receptors modulates the expression of PSA-NCAM a molecule related to neuronal structural plasticity, in the medial prefrontal cortex of adult rats. Experimental Neurology 2008, 214:97-111.
7. Castrén E. Is mood chemistry?. Nature Reviews. Neuroscience 2005, 6:241-246.
8. Connor C.M., Crawford B.C., Akbarian S. White matter neuron alterations in schizophrenia and related disorders. International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience 2011, 29:325-334.
9. Connor C.M., Guo Y., Akbarian S. Cingulate white matter neurons in schizophrenia and bipolar disorder. Biological Psychiatry 2009, 66:486-493.
10. Cook S.C., Wellman C.L. Chronic stress alters dendritic morphology in rat medial prefrontal cortex. Journal of Neurobiology 2004, 60:236-248.
11. Curley A.A., Arion D., Volk D.W., Asafu-Adjei J.K., Sampson A.R., Fish K.N., Lewis D.A. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. The American Journal of Psychiatry 2011, 168:921-929.
12. Duncan C.E., Webster M.J., Rothmond D.A., Bahn S., Elashoff M., Shannon Weickert C. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. Journal of Psychiatric Research 2010, 44:673-681.
13. Foley A.G., Rønn L.C.B., Murphy K.J., Regan C.M. Distribution of polysialylated neural cell adhesion molecule in rat septal nuclei and septohippocampal pathway: transient increase of polysialylated interneurons in the subtriangular septal zone during memory consolidation. Journal of Neuroscience Research 2003, 74:807-817.
14. Gilabert-Juan J., Castillo-Gomez E., Pérez-Rando M., Moltó M.D., Nacher J. Chronic stress induces changes in the structure of interneurons and in the expression of molecules related to neuronal structural plasticity and inhibitory neurotransmission in the amygdala of adult mice. Experimental Neurology 2011, 232:33-40.
15. Gilabert-Juan J., Moltó M.D., Nacher J. Post-weaning social isolation rearing influences the expression of molecules related to inhibitory neurotransmission and structural plasticity in the amygdala of adult rats. Brain Research 2012, 1448:129-136.
16. Gómez-Climent M.á., Guirado R., Castillo-Gómez E., Varea E., Gutierrez-Mecinas M., Gilabert-Juan J., Garcia-Mompo C., Vidueira S., Sanchez-Mataredona D., Hernandez S., Blasco-Ibanez J.M., Crespo C., Rutishauser U., Schachner M., Nacher J. The polysialylated form of the neural cell adhesion molecule (PSA-NCAM) is expressed in a subpopulation of mature cortical interneurons characterized by reduced structural features and connectivity. Cerebral Cortex 2011, 21:1028-1041.
17. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Archives of General Psychiatry 2007, 64:193-200.
18. Karolewicz B., Maciag D., O'Dwyer G., Stockmeier C.A., Feyissa A.M., Rajkowska G. Reduced level of glutamic acid decarboxylase-67kDa in the prefrontal cortex in major depression. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2010, 13:411-420.
19. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 2003, 169:215-233.
20. Krystal J.H., Sanacora G., Blumberg H., Anand A., Charney D.S., Marek G., Epperson C.N., Goddard A., Mason G.F. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry 2002, 7(Suppl. 1):S71-S80.
21. Lewis D.A., Curley A.A., Glausier J.R., Volk D.W. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends in Neurosciences 2012, 35:57-67.
22. Nacher J., Lanuza E., McEwen B.S. Distribution of PSA-NCAM expression in the amygdala of the adult rat. Neuroscience 2002, 113:479-484.
23. Oh D.H., Son H., Hwang S., Kim S.H. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2012, 22:330-338.
24. Phillips M.L., Drevets W.C., Rauch S.L., Lane R. Neurobiology of emotion perception II: implications for major psychiatric disorders. Biological Psychiatry 2003, 54:515-528.
25. Radley J.J., Rocher A.B., Miller M., Janssen W.G.M., Liston C., Hof P.R., McEwen B.S., Morrison J.H. Repeated stress induces dendritic spine loss in the rat medial prefrontal cortex. Cerebral Cortex 2006, 16:313-320.
26. Radley J.J., Sisti H.M., Hao J., Rocher A.B., McCall T., Hof P.R., McEwen B.S., Morrison J.H. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004, 125:1-6.
27. Rajkowska G., O'Dwyer G., Teleki Z., Stockmeier C.A., Miguel-Hidalgo J.J. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 2007, 32:471-482.
28. Rüsch N., Spoletini I., Wilke M., Bria P., Di Paola M., Di Iulio F., Martinotti G., Caltagirone C., Spalletta G. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophrenia Research 2007, 93:79-89.
29. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Archives of General Psychiatry 1999, 56:1043-1047.
30. Spokes E.G., Garrett N.J., Rossor M.N., Iversen L.L. Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects. Journal of the Neurological Sciences 1980, 48:303-313.
31. Sullivan P.F., Keefe R.S.E., Lange L.A., Lange E.M., Stroup T.S., Lieberman J., Maness P.F. NCAM1 and neurocognition in schizophrenia. Biological Psychiatry 2007, 61:902-910.
32. Tao R., Li C., Zheng Y., Qin W., Zhang J., Li X. Positive association between SIAT8B and schizophrenia in the Chinese Han population. Schizophrenia Research 2007, 90:108-114.
33. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Research 2000, 44:151-155.
34. Varea E., Blasco-Ibáñez J.M., Gómez-Climent M.A., Castillo-Gómez E., Crespo C., Martínez-Guijarro F.J. Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex. Neuropsychopharmacology 2007, 32:803-812.
35. Varea E., Castillo-Gómez E., Gómez-Climent M.A., Blasco-Ibáñez J.M., Crespo C., Martínez-Guijarro F.J. Chronic antidepressant treatment induces contrasting patterns of synaptophysin and PSA-NCAM expression in different regions of the adult rat telencephalon. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2007, 17:546-557.
36. Varea E., Castillo-Gómez E., Gómez-Climent M.A., Blasco-Ibáñez J.M., Crespo C., Martínez-Guijarro F.J. PSA-NCAM expression in the human prefrontal cortex. Journal of Chemical Neuroanatomy 2007, 33:202-209.
37. Varea E., Guirado R., Gilabert-Juan J., Martí U., Castillo-Gomez E., Blasco-Ibáñez J.M., Crespo C., Nacher J. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. Journal of Psychiatric Research 2012, 46:189-197.
38. Varea E., Nácher J., Blasco-Ibáñez J.M., Gómez-Climent M.A., Castillo-Gómez E., Crespo C., Martinez-Guijarro F.J. PSA-NCAM expression in the rat medial prefrontal cortex. Neuroscience 2005, 136:435-443.
39. Vawter M.P., Crook J.M., Hyde T.M., Kleinman J.E., Weinberger D.R., Becker K.G., Freed W.J. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophrenia Research 2002, 58:11-20.
40. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Archives of General Psychiatry 2000, 57:237-245.
41. Winterer G., Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neurosciences 2004, 27:683-690.